company background image
688278 logo

Xiamen Amoytop Biotech SHSE:688278 Stock Report

Last Price

CN¥83.20

Market Cap

CN¥33.8b

7D

6.4%

1Y

102.1%

Updated

21 Oct, 2024

Data

Company Financials +

Xiamen Amoytop Biotech Co., Ltd.

SHSE:688278 Stock Report

Market Cap: CN¥33.8b

Xiamen Amoytop Biotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Xiamen Amoytop Biotech
Historical stock prices
Current Share PriceCN¥83.20
52 Week HighCN¥86.11
52 Week LowCN¥40.40
Beta0.45
11 Month Change36.66%
3 Month Change61.21%
1 Year Change102.14%
33 Year Change233.07%
5 Year Changen/a
Change since IPO135.69%

Recent News & Updates

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Sep 19
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Recent updates

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Sep 19
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?

Jun 12
Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?

Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 04
Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk

Mar 25
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk

Shareholder Returns

688278CN BiotechsCN Market
7D6.4%1.7%2.7%
1Y102.1%-10.5%4.6%

Return vs Industry: 688278 exceeded the CN Biotechs industry which returned -10.5% over the past year.

Return vs Market: 688278 exceeded the CN Market which returned 4.6% over the past year.

Price Volatility

Is 688278's price volatile compared to industry and market?
688278 volatility
688278 Average Weekly Movement10.0%
Biotechs Industry Average Movement8.8%
Market Average Movement7.6%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.3%

Stable Share Price: 688278's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 688278's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
19962,106Li Sunwww.amoytop.com

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China.

Xiamen Amoytop Biotech Co., Ltd. Fundamentals Summary

How do Xiamen Amoytop Biotech's earnings and revenue compare to its market cap?
688278 fundamental statistics
Market capCN¥33.85b
Earnings (TTM)CN¥657.61m
Revenue (TTM)CN¥2.39b

51.5x

P/E Ratio

14.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688278 income statement (TTM)
RevenueCN¥2.39b
Cost of RevenueCN¥159.54m
Gross ProfitCN¥2.23b
Other ExpensesCN¥1.57b
EarningsCN¥657.61m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 25, 2024

Earnings per share (EPS)1.62
Gross Margin93.31%
Net Profit Margin27.56%
Debt/Equity Ratio0%

How did 688278 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

25%

Payout Ratio